FDA warns against widespread use of hydroxychloroquine.

Stimulife Health Blog

A malaria drug originally approved in 1955, to treat Covid-19 outside of the hospital or in the setting of a clinical trial. In a drug safety communication meant for health care providers, the FDA said it is “aware of reports of serious heart rhythm problems” in patients with Covid-19 treated with hydroxychloroquine or an older … Continue reading FDA warns against widespread use of hydroxychloroquine.